Home/Filings/4/0001127602-10-031610
4//SEC Filing

Rosenbaum Stanley 4

Accession 0001127602-10-031610

CIK 0001014739other

Filed

Dec 27, 7:00 PM ET

Accepted

Dec 28, 3:52 PM ET

Size

14.1 KB

Accession

0001127602-10-031610

Insider Transaction Report

Form 4
Period: 2010-12-27
Rosenbaum Stanley
Chief Financial Officer
Transactions
  • Sale

    Common Stock, $.0001 Par Value

    2010-12-28$5.16/sh30,284$156,265204,757 total
  • Exercise/Conversion

    Common Stock, $.0001 Par Value

    2010-12-27$2.47/sh+39,688$98,029244,445 total
  • Exercise/Conversion

    Common Stock, $.0001 Par Value

    2010-12-28$2.47/sh+30,284$74,801235,041 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2010-12-2739,68830,284 total
    Exercise: $2.47From: 2007-11-01Exp: 2016-11-01Common Stock, $.0001 Par Value (39,688 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2010-12-2830,2840 total
    Exercise: $2.47From: 2007-11-01Exp: 2016-11-01Common Stock, $.0001 Par Value (30,284 underlying)
  • Sale

    Common Stock, $.0001 Par Value

    2010-12-27$5.15/sh39,688$204,393204,757 total
Footnotes (1)
  • [F1]Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.

Issuer

BioScrip, Inc.

CIK 0001014739

Entity typeother

Related Parties

1
  • filerCIK 0001365999

Filing Metadata

Form type
4
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 3:52 PM ET
Size
14.1 KB